Clinical Evaluation of the Access Socket Flexible Socket for Transtibial Prosthesis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUnion de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est

About this trial

Transtibial amputation significantly impacts patient autonomy and quality of life, primarily due to the limitations of conventional rigid sockets, which restrict comfort and joint range of motion. The Access Socket (AS) is an innovative prosthetic socket combining a rigid carbon-fiber structure in key load-bearing areas with flexible urethane-resin (ProtheFLEX®) zones in regions typically rigid in conventional sockets. This hybrid design aims to improve comfort and pressure distribution while preserving the mechanical properties required for ambulation.

The AS has already demonstrated benefits in transfemoral amputees and is now reimbursed in France for that population. A preliminary uncontrolled study in 12 transtibial amputees suggested significant improvements in perceived function, comfort, satisfaction, and mobility.

This multicenter, randomized, open-label, two-arm crossover study aims to compare the (AS) with the standard rigid socket (RS) in 25 adults with transtibial amputation. Participants will wear each socket for approximately 4 weeks (after a 1-2 week adaptation period) in a randomized order. The primary outcome is the Patient Specific Functional Scale (PSFS). Secondary outcomes include comfort (SCS), satisfaction (OPUS), psychosocial adjustment (TAPES-R), mobility (PLUS-M), prosthesis utility (PEQ-U), and the proportion of patients electing to keep the AS at study completion.

Eligibility criteria

Qualifiers

Unilateral or bilateral transtibial amputation

Currently fitted with a definitive carbon rigid socket

Any residual-limb shape

Any etiology

Disqualifiers

Use of hydroalcoholic solution (HAS) for socket donning

Currently fitted with a provisional socket

Neurological pathology limiting capacity to participate in activities

Orthopedic pathology limiting capacity to participate in activities

Trial design

Treatments tested in this trial

  • Access Socket (AS)
  • Rigid Socket (RS)

Treatment groups

25 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est

Lead sponsor

Institution Nationale des Invalides

Collaborator

Hôpital Filieris de Freyming-Merlebach

Collaborator

Ortho Access

Collaborator

H20 Orthopedie

Collaborator

Otto Bock France SNC

Collaborator

Hôpital d'Instruction des armées Percy

Collaborator

Clinical Investigation Center - University Hospital Grenoble

Collaborator